HEXO Is Surging Ahead of Earnings: Should You Be Buying?

 HEXO Corp (TSX:HEXO)(NYSE:HEXO) is releasing its quarterly results later this week, which will be a big test for the company.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

It could be a big week for HEXO (TSX:HEXO)(NYSE:HEXO), as the pot producer releases its third-quarter earnings on Thursday before the markets open. Shares of the company have been soaring over the past month, as they’re up more than 70%. On Monday, the stock was up more than 20% by midday. Here’s how it’s done of late compared to its peers:

HEXO Chart

The stock’s been performing very well recently, but over the past year the results tell a bit of a different story:

HEXO Chart

What can we attribute these gains to?

The markets as a whole have been fairly bullish over the past few weeks. There’s been growing optimism, as cities in North America have been reopening. There’s hope that the COVID-19 pandemic may not have as disastrous an impact on the economy as once feared. And for stocks like HEXO that have incurred significant losses over the past year, it’s made them more attractive buys in the process. After all, if the economy’s doing better, then there will be more consumers making discretionary purchases, and that means more pot buying.

But where the stock goes from here will largely depend on how it does in its upcoming earnings release.

What investors should look for when the company releases earnings

HEXO has incurred a loss in each of its last 10 quarterly results. It would be nothing short of shocking if the company were to post a profit, especially since in its last quarter it had a mammoth $298 million loss. That was due to some sizeable writedowns that weighed the company’s bottom line down. However, HEXO had a negative gross margin, so profitability wasn’t going to happen with or without the writedowns.

It’s a given that HEXO will occur a loss in its third quarter; the only question is how big it will be.

The one thing investors should keep an eye out for is impairments and whether they reoccur, and if so, to what degree? Another series of large writedowns could send the stock crashing despite its recent gains. Another area investors will want to look for is whether HEXO’s growing its sales — something that hasn’t been an automatic in the cannabis industry this year. HEXO’s value brand should help take revenue away from the black market, but it may not be enough to offset the downturn that COVID-19 may have caused in recent months.

Is HEXO a buy?

Investors are taking on a big risk when buying a stock that’s rallying significantly heading into earnings. It’s a sign that there’s a lot of excitement heading into earnings, and that also means expectations will be high for the company to do well. Canopy Growth didn’t post impressive sales numbers when it released its most recent earnings, and that was even as the industry saw lots of panic buying in March. HEXO’s earnings will go until the end of April when panic buying slowed.

Despite HEXO’s decline over the past year, there are more reasons to expect a poor showing in Q3 than there are that the company will beat expectations. And that’s why I wouldn’t get on the bandwagon, especially as the stock’s near its three-month high. Investors could incur significant losses if the company doesn’t post an amazing performance this week.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »